Drug Trial Radar · NCT06023706
Study Evaluating the Analgesic Efficacy of Capsaicin 8% Patches in Chronic Coccygodynia.
Last checked: Nov 20, 2026Latest source record: Oct 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
188
Planned (sponsor's estimate)
Start
Nov 8, 2023
Primary completion
May 8, 2027
Study completion Oct 8, 2027
Sponsor
- Lead sponsor
- Nantes University HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Sep 5, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective is to demonstrate the analgesic effect at day 60 of 8% capsaicin patch (Qutenza) for the treatment of patients with coccygodyinia.
Conditions
- Coccyx Disorder
- Neuropathic Pain
- Coccygodynia
Interventions
Capsaicin 179 Mg Cutaneous PatchDrug
1 patch applied once for 1 hour
Capsaicin low concentration patch (capsaicin 0,04%, 3,2 mg/cm2)Drug
1 patch applied once for 1 hour
Primary outcomes
What the sponsor says the trial is designed to measure.
- to demonstrate the analgesic effect at day 60 of 8% capsaicin patch (Qutenza) for the treatment of patients with coccygodyinia.Time frame: Day 60
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Brest University Hospital
Brest, France · Recruiting
Vendée Departmental Hospital
La Roche-sur-Yon, France · Recruiting
Confluent Private Hospital Centre
Nantes, France · Recruiting
Nantes University Hospital
Nantes, France · Recruiting
GH Paris saint Joseph
Paris, France · Recruiting
Rouen University Hospital
Rouen, France · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.